These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9455826)
1. The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome. Mathur RS; Jenkins JM; Bansal AS Hum Reprod; 1997 Dec; 12(12):2629-34. PubMed ID: 9455826 [TBL] [Abstract][Full Text] [Related]
2. Ovarian hyperstimulation syndrome: a new insight into an old enigma. Orvieto R; Ben-Rafael Z J Soc Gynecol Investig; 1998; 5(3):110-3. PubMed ID: 9614638 [TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Rizk B; Aboulghar M; Smitz J; Ron-El R Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101 [TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786 [TBL] [Abstract][Full Text] [Related]
5. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621 [TBL] [Abstract][Full Text] [Related]
6. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997 [TBL] [Abstract][Full Text] [Related]
8. Cytokine levels in a patient with severe ovarian hyperstimulation syndrome before and after the ultrafiltration and reinfusion of ascitic fluid. Ito M; Harada T; Iwabe T; Tanikawa M; Terakawa N J Assist Reprod Genet; 2000 Feb; 17(2):118-20. PubMed ID: 10806592 [TBL] [Abstract][Full Text] [Related]
9. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome. Chen CD; Chen HF; Lu HF; Chen SU; Ho HN; Yang YS Hum Reprod; 2000 May; 15(5):1037-42. PubMed ID: 10783347 [TBL] [Abstract][Full Text] [Related]
10. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome. Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159 [TBL] [Abstract][Full Text] [Related]
12. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome? Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Abramov Y; Barak V; Nisman B; Schenker JG Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600 [TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647 [TBL] [Abstract][Full Text] [Related]
15. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model. Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396 [TBL] [Abstract][Full Text] [Related]
16. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. Levin ER; Rosen GF; Cassidenti DL; Yee B; Meldrum D; Wisot A; Pedram A J Clin Invest; 1998 Dec; 102(11):1978-85. PubMed ID: 9835623 [TBL] [Abstract][Full Text] [Related]
17. Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome. Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS Hum Reprod; 2000 Jan; 15(1):66-71. PubMed ID: 10611190 [TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240 [TBL] [Abstract][Full Text] [Related]
19. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome]. Liang W; Chen S; Xing F Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687 [TBL] [Abstract][Full Text] [Related]
20. The immune system in severe ovarian hyperstimulation syndrome. Orvieto R; Ben-Rafael Z Isr J Med Sci; 1996 Dec; 32(12):1180-2. PubMed ID: 9007149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]